Q301--New - Referral Lab Testing NTX 36C25722D0064
Summary
AI-generated · Jun 06, 2026A sole-source, out-of-scope modification to an existing IDIQ Firm-Fixed-Price contract currently held by Mayo Collaborative Services will add referral lab testing for the North Texas Veterans Health Care’s Pathology and Laboratory Department in Dallas. The added tests include: UBA1 Mutation Quant (CPT 81403) with an estimated annual volume of 4; Prothrombin G20210A Mutation, Blood (CPT 81240-F2) with 4; TP53 Mutation, NGS (CPT 88381, 81351) with 5; Chronic Lymphocytic Leukemia FISH Diagnostics (88271x12, 88275x6, 88291) with 4; PKLR Full gene analysis (CPT 81405) with 4; B-cell lymphoma NGS (CPT 81450) with 4; UDP-Glucuronosyltransferase 1A1 (UGT1A1) (CPT 81404) with 4; Copper, Liver Tissue (CPT 82525) with 5; and CNS Demyelinating Disease Evaluation, Serum (CPT 86053, 86363) with 3.
This action is authorized under 41 U.S.C. 1901 as implemented by FAR 6.103-1(c); acquisitions under simplified procedures are exempt from FAR Part 6. A copy of the justification will be publicly available within 14 days of modification execution per FAR 6.301. This notice is not a competitive solicitation, but all responsible sources may submit a capability statement for agency consideration, which will typically be used only to determine whether a competitive procurement should be pursued in the future. The government may decide not to compete based on responses.
The Government intends to negotiate and award a sole-source, out-of-scope modification to an existing IDIQ Firm-Fixed-Price (FFP) contract currently held by Mayo Collaborative Services, LLC. This modification will add additional referral Lab Testing to the North Texas Veterans Health Care, 4500 South Lancaster Road, Dallas, TX 75216 Pathology and Laboratory Department. Additional lab testing added as follows: Item Number Test Name CPT Codes Estimated Annual Test Volume 3032 4032 UBA1Mutation Quant 81403 4 3033 4033 Prothrobmin G20210A Mutation, Blood 81240-F2 4 3034 4034 TP53 Mutation, NGS 88381, 81351 5 3035 4035 Chronic Lymphocytic Leukemia FISH Diagnostics 88271x12, 88275x6, 88291 4 3036 4036 PKLR Full gene analysis 81405 4 3037 4037 B-cell lymphoma NGS 81450 4 3038 4038 UDP-Glucuronosyltransferase 1A1 (UGT1A1) 81404 4 3039 4039 Copper, Liver Tissue 82525 5 3040 4040 CNS Demyelinating Disease Evaluation, Serum 86053,86363 3 The statutory authority permitting this sole source acquisition is 41 U.S.C. 1901 as implemented by RFO FAR 6.103-1 (c ). Acquisitions conducted under simplified acquisition procedures are exempt from the requirements in FAR Part 6. A copy of the justification will made publicly available within 14 days of modification execution in accordance with RFO FAR 6.301. This notice of intent is NOT a request for competitive proposals. However, all responsible sources may submit a capability statement which shall be considered by the agency. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement in the future. A determination by the Government not to compete this proposed action based upon responses to this notice is solely within the discretion of the Government
From Special Notice posted on Jun 05, 2026Notice history
1-
Special Notice LATEST Posted Jun 05, 2026
Details
Award Information
Contacts
Contracting Specialist
Phone